Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, and in compliance with the applicable provisions of the Companies Act, 2013 and the rules made thereunder, below are the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences Limited held its 43rd Annual General Meeting on September 25, 2025, conducted via video conferencing. At the meeting, members passed two special resolutions. The first regularized the appointment of Mr. Hitesh Pradeep Rijwani as a Non-Executive Independent Director for a five-year term effective May 12, 2025, to May 11, 2030. The second approved the appointment of Mr. Sarang Bharatbhai Pathak as a Non-Executive Non-Independent Director for a five-year term effective August 30, 2025, to August 29, 2030. The company has submitted the certified true copies of these resolutions to BSE under SEBI LODR Regulation 30. This is a routine post-AGM compliance filing.
This is a routine corporate governance disclosure with no direct financial impact on shareholders. The appointments fill board positions and ensure compliance with listing requirements, but do not change the company's business outlook.